Best peptides for joint and tendon healing

BPC-157 has the largest volume of published preclinical data for tendon and ligament repair among any research peptide. Rodent studies show accelerated tendon-to-bone healing, improved tensile strength, and promotion of fibroblast proliferation. Its proposed mechanism — NO-pathway activation and VEGF upregulation — is mechanistically relevant to connective tissue regeneration. Human evidence is limited to a single small pilot (n=2) that reported no adverse events but could not establish efficacy.

TB-500 is a thymosin beta-4 fragment studied primarily in cardiac muscle repair models, with proposed extension to skeletal connective tissue via actin regulation and angiogenesis signaling. Its mechanism — promoting endothelial cell migration and new blood vessel formation — is relevant to connective tissue healing which depends on revascularization. Frequently co-administered with BPC-157 in community protocols.

GHK-Cu's relevance to joint and tendon healing centers on its role in collagen synthesis stimulation and matrix metalloproteinase regulation — both critical processes in connective tissue remodeling. Cell culture studies show upregulation of collagen and elastin production. Its most accessible human-use data are from topical cosmetic applications; systemic effects on tendons and joints in humans have not been studied.